Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID Reference, 5th edition, 486 pages

Free download


  Malignant Melanoma

  Free Subscription


23.11.2020

3 Am J Dermatopathol
2 Ann Surg Oncol
1 Br J Cancer
1 Br J Dermatol
1 Cancer Res
3 Clin Cancer Res
1 Cutis
1 Eur J Dermatol
1 Int J Cancer
1 JAMA
1 Melanoma Res
1 Oncogene
2 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Dermatopathol

  1. DONATI M, Nozicka J, Kastnerova L, Hajkova V, et al
    Primary Cutaneous Desmoplastic Melanoma With Collagen Rosettes and Pseudoglandular Features.
    Am J Dermatopathol. 2020 Nov 16. doi: 10.1097/DAD.0000000000001809.
    PubMed         Abstract available

  2. TORRE-CASTRO J, Haya-Martinez L, Moya-Martinez C, Nunez-Hipolito L, et al
    Syringotropic Melanoma: A Diagnostic Challenge With Prognostic Implications.
    Am J Dermatopathol. 2020 Nov 16. doi: 10.1097/DAD.0000000000001853.
    PubMed         Abstract available

  3. DONATI M, Kastnerova L, Martinek P, Grossmann P, et al
    Spitz Tumors With ROS1 Fusions: A Clinicopathological Study of 6 Cases, Including FISH for Chromosomal Copy Number Alterations and Mutation Analysis Using Next-Generation Sequencing.
    Am J Dermatopathol. 2020;42:92-102.
    PubMed         Abstract available


    Ann Surg Oncol

  4. FARROW NE, Holl EK, Jung J, Gao J, et al
    Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.
    Ann Surg Oncol. 2020 Nov 17. pii: 10.1245/s10434-020-09277.
    PubMed         Abstract available

  5. LI W, Xiao Y, Xu X, Zhang Y, et al
    A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
    Ann Surg Oncol. 2020 Nov 15. pii: 10.1245/s10434-020-09341.
    PubMed         Abstract available


    Br J Cancer

  6. KUMAR PR, Moore JA, Bowles KM, Rushworth SA, et al
    Mitochondrial oxidative phosphorylation in cutaneous melanoma.
    Br J Cancer. 2020 Nov 18. pii: 10.1038/s41416-020-01159.
    PubMed         Abstract available


    Br J Dermatol

  7. NAKAMURA M, Obayashi M, Yoshimitsu M, Kato H, et al
    Comparative whole-exome sequencing of an ultra-late recurrent malignant melanoma.
    Br J Dermatol. 2020 Nov 18. doi: 10.1111/bjd.19680.
    PubMed         Abstract available


    Cancer Res

  8. PORTA C, Consonni FM, Morlacchi S, Sangaletti S, et al
    Tumor-Derived Prostaglandin E2 Promotes p50 NF-kappaB-Dependent Differentiation of Monocytic MDSCs.
    Cancer Res. 2020;80:2874-2888.
    PubMed         Abstract available


    Clin Cancer Res

  9. WATANABE T, Gaedicke S, Guffart E, Firat E, et al
    Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8(+) T-Cell-Dependent Tumor Activity.
    Clin Cancer Res. 2020;26:945-956.
    PubMed         Abstract available

  10. MUELLER KL, Theoret MR, Lemery SJ, Amiri-Kordestani L, et al
    Neoadjuvant Therapy for Melanoma: A US Food and Drug Administration - Melanoma Research Alliance Public Workshop.
    Clin Cancer Res. 2020 Nov 13. pii: 1078-0432.CCR-20-3285.
    PubMed         Abstract available

  11. JOHANNET P, Coudray N, Donnelly DM, Jour G, et al
    Using Machine Learning Algorithms to Predict Immunotherapy Response in Patients with Advanced Melanoma.
    Clin Cancer Res. 2020 Nov 18. pii: 1078-0432.CCR-20-2415.
    PubMed         Abstract available


    Cutis

  12. CONDIE D, Fathi R, Nijhawan RI
    Cartilage sutures for a large nasal defect.
    Cutis. 2020;105:44-45.
    PubMed         Abstract available


    Eur J Dermatol

  13. GRAN F, Weber J, Schummer P, Kneitz H, et al
    Sarcoidosis developing upon immune checkpoint inhibition in advanced uveal melanoma.
    Eur J Dermatol. 2020;30:629-631.
    PubMed        


    Int J Cancer

  14. DELLAC S, Ben-Dov H, Raanan A, Saleem H, et al
    Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus.
    Int J Cancer. 2020 Nov 16. doi: 10.1002/ijc.33401.
    PubMed         Abstract available


    JAMA

  15. ALDUBAYAN SH, Conway JR, Camp SY, Witkowski L, et al
    Detection of Pathogenic Variants With Germline Genetic Testing Using Deep Learning vs Standard Methods in Patients With Prostate Cancer and Melanoma.
    JAMA. 2020;324:1957-1969.
    PubMed         Abstract available


    Melanoma Res

  16. LIU WK, Naban N, Kaul A, Patel N, et al
    Life-threatening polymyositis with spontaneous hematoma induced by nivolumab in a patient with previously resected melanoma.
    Melanoma Res. 2020 Nov 13. doi: 10.1097/CMR.0000000000000706.
    PubMed         Abstract available


    Oncogene

  17. HAN A, Purwin TJ, Bechtel N, Liao C, et al
    BAP1 mutant uveal melanoma is stratified by metabolic phenotypes with distinct vulnerability to metabolic inhibitors.
    Oncogene. 2020 Nov 18. pii: 10.1038/s41388-020-01554.
    PubMed         Abstract available


    PLoS One

  18. GANBAATAR O, Konnai S, Okagawa T, Nojima Y, et al
    PD-L1 expression in equine malignant melanoma and functional effects of PD-L1 blockade.
    PLoS One. 2020;15:e0234218.
    PubMed         Abstract available

  19. LUO H, Ma C
    Identification of prognostic genes in uveal melanoma microenvironment.
    PLoS One. 2020;15:e0242263.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: